Not logged in Consistent clinical factor VIII equivalency is unlikely for non-factor therapies in hemophilic mice (vol 110, pg 2064, 2025) Sefiane, Thibaud; McCluskey, Genevieve; Clavel, Marie; Maynadie, Hortense; Peyron, Ivan; David, Tovo; Brochier, Camille; Saller, Francois; Khamari, Mariem; Denis, Cecile, V; Christophe, Olivier D.; Lenting, Peter J.; Muczynski, Vincent; Casari, Caterina Share Save
Share Save
Differences in venous clot structures between hemophilic mice treated with emicizumab versus factor VIII or factor VIIIFc Sefiane, Thibaud; Maynadie, Hortense; Ettingshausen, Carmen Escurola; Muczynski, Vincent; Heiligenstein, Xavier; Dumont, Julien; Christophe, Olivier D.; Denis, Cecile, V; Casari, Caterina; Lenting, Peter J. Share Save
Share Save
Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity Cherif, Chaima; Nguyen, Dang Tan; Paris, Clement; Le, Thi Khanh; Sefiane, Thibaud; Carbuccia, Nadine; Finetti, Pascal; Chaffanet, Max; El Kaoutari, Abdessamad; Vernerey, Julien; Fazli, Ladan; Gleave, Martin; Manai, Mohamed; Barthelemy, Philippe; Birnbaum, Daniel; Bertucci, Francois; Taieb, David; Rocchi, Palma Share Save
Non-inhibitory antibodies inducing increased emicizumab clearance in a severe hemophilia A inhibitor patient Harroche, Annie; Sefiane, Thibaud; Desvages, Maximilien; Borgel, Delphine; Lasne, Dominique; Casari, Caterina; Peyron, Ivan; Frenzel, Laurent; Chhun, Stephanie; Lenting, Peter J.; Bally, Cecile Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
